News

generic

Creo Pharma Transfers of Value (ToV) for 2017 to Healthcare Professionals

26/06/18
Creo Pharma Transfers of Value (ToV) for 2017 to Healthcare Professionals

As a member of the BGMA, Creo Pharma are signed up to the Medicines for Europe Code of Conduct. 

The information below is Creo Pharma’s 'Transfers of Value' disclosure for 2017.

The code is inclusive of all Healthcare Professionals who received a transfer of value from Creo Pharma. This disclosure ensures Creo Pharma’s continued compliance with the Medicines for Europe Code of Conduct. 

 

Transfers of Value to HCPs for fees for service and consultancy.

UK definition for HCPs based on Code of Conduct:

Includes those working: for a pharmacy or pharmacy group; as well as doctors and CCG staff; NHS and Government employees, such as in hospitals or senior policy makers; those working for private and non for profit health providers. Does not include those working for distributors and wholesalers and others providing intermediary service.

Company

Creo Pharma

Date of disclosure

June 2018

Number of HCPs received ToV in 2017

5

Type of fees for services and consultancy

Consultancy teleconferences

Aggregated Amount / Value of ToV

£975

 

Source: Code of Conduct, Section 7.1, page 14.

Includes contracted amount for fees for services.
Does not include expenses such as travel, accommodation and meals.
Does not include fees for R&D or market research.